SP7 and breast cancer: This study has demonstrated that low osterix protein expression in the nucleus, but not cytoplasm, was associated with adverse disease specific survival and time to distant metastasis in a large, well annotated cohort of breast cancer patients (P = 0.016 and P = 0.003 respectively).